1.Analysis of the effect of metabolic parameters on the self-efficacy in patients with diabetes mellitus
Chinese Journal of Practical Nursing 2013;(11):19-22
Objective To investigate the effect of metabolic parameters on the self-efficacy in patients with diabetes mellitus.Methods 175 diabetes mellitus patients were recruited by random sampling method.Demographic data and metabolic parameters were obtained and the scales of self-efficacy of diabetes patients were evaluated by secd6.We further analyzed the effect of metabolic parameters on the selfeffficacy in diabetes mellitus patients.Results Two-hour postprandial blood glucose had negative correlation with self-efficacy among 10 metabolic parameters in diabetes mellitus patients.Conclusions Twohour post-prandial hyperglycemia affects the scale of self-effcacy.So we should strengthen the management of two-hour postprandial hyperglycemia to increase the self-efficacy in diabetes mellitus patients.
2.Determinants on aged population’s health expenditures in China
Chinese Journal of Health Policy 2015;(7):68-73
Objective:To provide references for policy-making on the establishment of a sound healthcare sys-tem for China’s aged population. Methods:Based on the framework of The Behavioral Model of Health Services Use and data from China Health and Retirement Longitudinal Study in 2011 , the Tobit model of aged population’s health expenditures is built. Results: Self-rated health conditions, chronic disease, medical insurance, endowment insur-ance, self-rated living standard, age, gender, marital status and urban-rural character are the significant determi-nants. Conclusions:The healthcare system for China’s aged population should be built through simultaneously apply-ing disease prevention and access facilitation policies and the characteristic differences of different groups of aged pop-ulation should be taken into consideration.
3.Influence of Regulation on the Stock Trade between Retailers and Suppliers on Drug Retailing
China Pharmacy 1991;0(05):-
OBJECTIVE:To discuss the possible influence of the Regulation on the Stock Trade between Retailers and Suppliers(which was called in the following as “Regulation” for short) on drug retailing for the reference of drug retailers and suppliers.METHODS:The origin and the status quo of “Regulation” were studied and the influence of which on drug retailing was analyzed.RESULTS & CONCLUSION:Drug retailing was considerably influenced by policy factor,this issue of “Regula_tion” may change some unfair business behaviors such as delaying in payment and charging unreasonable entrance fee,and influences the strength contrast between drug retailers and suppliers.
4.Opportunities and Challenges for the Expanding of Traditional Chinese Medicine in European Union Herbal Drug Market
China Pharmacy 2001;0(07):-
OBJECTIVE:To facilitate a better understanding of the European Union(EU)herbal drugs market for Chinese TCM enterprises and to promote the internationalization of Chinese traditional medicines.METHODS:The opportunities and challenges confronted by TCM enterprises in their expanding of their products in the EU herbal medicine market were analyzed based on the knowledge about market size,market segmentation,consumption patters and developmental tendencies of the EU herbal medicine market.RESULTS&CONCLUSIONS:There were both opportunities and challenges for the expanding of traditional Chinese medicines in the EU herbal medicine market,yet on the whole,the opportunities were more than the challenge.Chinese enterprises should strive to further expand the EU herbal medicine market.
5.Governmental Price-Cutting Policy and Expelling of Low Price Drugs from Market by High Price Drugs
China Pharmacy 2001;0(10):-
OBJECTIVE:To put forward proposals for governments on how to properly regulate drug market.METHODS:The theory of price elasticity in economics was applied for the analysis.RESULTS & CONCLUSIONS:With the increasing of national income year by year,the cases for high price drugs to expel low price drugs has become increasingly common.The government policies should be based on the development of pharmaceutical industry,meanwhile government should take mild policy to ease the contradictions arose from the development.
6.Carrying Out Pharmacoeconomic Study in China:Necessity,Problems and Suggestions
China Pharmacy 2005;0(20):-
OBJECTIVE:To promote the development and make full use of the pharmacoeconomics(PE)in China.METHODS:The problems to be able to solved using PE,i.e the necessity of developing PE in China was discussed,and the bottleneck which will restrain or hinder the optimal utilization of PE was pointed out.RESULTS:We should strengthen the cultivation of talents engaged in PE,formulating guidelines of pharmacoeconomic evaluation and gradually apply PE into National Essential Medicine Policy.CONCLUSION:The decision-makers of health policy should have a sufficient understanding of PE so as to facilitate the utilization and sustainable development of PE in health policy-related decision-making.
7.Brief Introduction on the Disclosure of FDA Information in US and Its Implication
China Pharmacy 2005;0(22):-
OBJECTIVE:To provide reference for food & drug regulatory authorities in China to disclose government information.METHODS:In the light of the development and status quo of the disclosure of information in US FDA,the access,content and procedure for the disclosure of information in FDA were discussed.RESULTS & CONCLUSIONS:There are many similarities between US and China in the disclosure of information.In view of the practical situation of governmental information disclosure in food and drug regulatory authorities in China,Chinese government should be able to find out such key issues as the human and financial support is much needed in FDA information disclosure,the disclosure level should be in line with our national condition,a three-dimensional publicity system of government information at different level should be established and emphasis should be laid to the key disclosed information etc based on the research on the development,access,content and procedure of information disclosure in FDA.
8.Discussion on the Strategy of Chain Drugstores in Replying to Drug Price War
China Pharmacy 1991;0(06):-
OBJECTIVE:To provide the ideas about how the chain drugstores to reply to drug price war.METHODS:Economically,the competition between drugstore was discussed and the respective advantages and disadvantages of fair-price and chain drugstores were analysed.RESULTS &CONCLUSION:Chain drugstores should improve their pharmaceutical service,base oneself upon market voids,and exert self-advantages,if they want to win in price war.
9.Standardization of Antibiotics Sales and Promotion of Reasonable Drug Use
China Pharmacy 1991;0(03):-
OBJECTIVE:To promote the reasonable use of antibiotic drugs.METHODS:the causes of antibiotics drug abuse were analyzed.The regulation on standardizing antibiotic drug sales by State Food and Drug Administration as well as its influence were discussed.RESULTS&CONCLUSION:some conceptions and suggestions are tentatively put forward.
10.The Application of Customer Relationship Management in Retail Drugstores
China Pharmacy 1991;0(04):-
OBJECTIVE:To provide advices on how to apply to the theory of customer relationship management in retail drugstores.METHODS:The theory of customer relationship management was briefly expounded and its application in the real management of drugstores was analyzed.RESULTS&CONCLUSION:Only after the retail drugstore putting the ideas of customer relationship management into their everyday work according to their own features can their function brought into full play.